Chabiotech차바이오텍
085660 · KOSDAQ · ₩085660 · 차바이오텍
₩6,760▼ ₩320 (4.52%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 29, 2026Open on DART
Predicted impact: Low
- [Amended] Decision on Provision of Collateral for Third Parties[기재정정]타인에대한담보제공결정Oct 16, 2026Open on DART
Predicted impact: Low
- [Amended] Decision on Provision of Collateral for Third Parties[기재정정]타인에대한담보제공결정Sep 30, 2026Open on DART
- [Amended] Decision on Provision of Collateral for Third Parties[기재정정]타인에대한담보제공결정Sep 28, 2026Open on DART
- Adjustment of Conversion Price for Convertible Shares (Redeemable Convertible Preferred Shares)전환주식의전환가액조정 (상환전환우선주)Sep 17, 2026Open on DART
- Adjustment of Exercise Price of Warrants신주인수권행사가액의조정Sep 16, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 14, 2026Open on DART
- [Amended] Decision on Provision of Collateral for Third Parties[기재정정]타인에대한담보제공결정Sep 10, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 3, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Aug 18, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Aug 18, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
- Amended: Acquisition of shares in another company[기재정정]타법인주식및출자증권취득결정Jun 26, 2026Open on DART
- Decision to Acquire Exchangeable Bonds Before Maturity (10th Series)자기교환사채만기전취득결정 (제10회차)Jun 26, 2026Open on DART
- Decision to Provide Collateral for Third Party타인에대한담보제공결정Jun 26, 2026Open on DART
- Rights offering (paid-in capital increase) decision유상증자결정(종속회사의주요경영사항)Jun 26, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Jun 26, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Jun 18, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 9, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고May 18, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 6, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 27, 2026Open on DART
- Sale of shares in another company타법인주식및출자증권처분결정Apr 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 1, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Mar 31, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 17, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 17, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
- Sale of shares in another company타법인주식및출자증권처분결정(자율공시)Mar 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 11, 2026Open on DART
- Material Matters Report (Exercise of Stock Options by Third Party of Convertible Shares)주요사항보고서(제3자의전환주식매수선택권행사)Mar 5, 2026Open on DART
- Major Matters Report (Exercise of Call Option on Third-Party Bonds with Subscription Rights for New Shares)주요사항보고서(제3자의신주인수권부사채매수선택권행사)Mar 5, 2026Open on DART
- Major Matters Report (Exercise of Convertible Bond Call Option by Third Party)주요사항보고서(제3자의전환사채매수선택권행사)Mar 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 5, 2026Open on DART
- Change of CEO대표이사변경Mar 4, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 27, 2026Open on DART
- Adjustment of Conversion Price for Convertible Shares (Redeemable Convertible Preferred Shares)전환주식의전환가액조정 (상환전환우선주)Feb 19, 2026Open on DART
- Adjustment of Exercise Price of Warrants신주인수권행사가액의조정Feb 19, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Feb 19, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Chabiotech / 차바이오텍 / 085660 / KRX:085660
Source: KRX statistical information